Page last updated: 2024-08-23

amikacin and Wet Macular Degeneration

amikacin has been researched along with Wet Macular Degeneration in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Damasceno, EF; Damasceno, NP; Horowitz, SA	1

Other Studies

1 other study(ies) available for amikacin and Wet Macular Degeneration

Article	Year
Leuconostoc as a Cause of Endophthalmitis Post-intravitreal Injection of Ranibizumab. Ocular immunology and inflammation, 2016, Volume: 24, Issue:1 Topics: Aged, 80 and over; Amikacin; Angiogenesis Inhibitors; Anti-Bacterial Agents; Endophthalmitis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Intravitreal Injections; Leuconostoc; Male; Postoperative Complications; Ranibizumab; Vascular Endothelial Growth Factor A; Vitreous Body; Wet Macular Degeneration	2016

Article

Year

Leuconostoc as a Cause of Endophthalmitis Post-intravitreal Injection of Ranibizumab.

Ocular immunology and inflammation, 2016, Volume: 24, Issue:1

Topics: Aged, 80 and over; Amikacin; Angiogenesis Inhibitors; Anti-Bacterial Agents; Endophthalmitis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Intravitreal Injections; Leuconostoc; Male; Postoperative Complications; Ranibizumab; Vascular Endothelial Growth Factor A; Vitreous Body; Wet Macular Degeneration

2016